BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37675734)

  • 1. Prognostic and pathological implications of contrast-enhanced ultrasound features in hepatocellular carcinoma.
    Wang Y; Chai S; Cai W; Yu J; Liang P
    J Cancer Res Ther; 2023 Aug; 19(4):1040-1047. PubMed ID: 37675734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on correlation between two-dimensional ultrasound, contrast-enhanced ultrasound and microvascular invasion in hepatocellular carcinoma.
    Wang P; Nie F; Dong T; Wang G; Wang L; Fan X
    Clin Hemorheol Microcirc; 2022; 80(2):97-106. PubMed ID: 34057142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
    Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
    Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
    Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
    World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
    Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
    Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters.
    Wang L; Feng B; Li D; Liang M; Wang S; Wang S; Ma X; Zhao X
    Eur Radiol; 2023 May; 33(5):3592-3603. PubMed ID: 36884087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Microvascular Invasion in Combined Hepatocellular-Cholangiocarcinoma Based on Pre-operative Clinical Data and Contrast-Enhanced Ultrasound Characteristics.
    Chen Y; Lu Q; Zhu Y; Huang B; Dong Y; Wang W
    Ultrasound Med Biol; 2022 Jul; 48(7):1190-1201. PubMed ID: 35397928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning of Liver Contrast-Enhanced Ultrasound to Predict Microvascular Invasion and Prognosis in Hepatocellular Carcinoma.
    Zhang Y; Wei Q; Huang Y; Yao Z; Yan C; Zou X; Han J; Li Q; Mao R; Liao Y; Cao L; Lin M; Zhou X; Tang X; Hu Y; Li L; Wang Y; Yu J; Zhou J
    Front Oncol; 2022; 12():878061. PubMed ID: 35875110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomics features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study.
    Dong Y; Zuo D; Qiu YJ; Cao JY; Wang HZ; Yu LY; Wang WP
    Clin Hemorheol Microcirc; 2022; 81(1):97-107. PubMed ID: 35001883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma.
    Sun BY; Gu PY; Guan RY; Zhou C; Lu JW; Yang ZF; Pan C; Zhou PY; Zhu YP; Li JR; Wang ZT; Gao SS; Gan W; Yi Y; Luo Y; Qiu SJ
    World J Surg Oncol; 2022 Jun; 20(1):189. PubMed ID: 35676669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
    Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
    J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma.
    Nitta H; Allard MA; Sebagh M; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Lewin M; Samuel D; Baba H; Adam R
    Ann Surg Oncol; 2019 Aug; 26(8):2568-2576. PubMed ID: 31054040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology.
    He Y; Liu F; Mou S; Li Q; Wang S
    Oncol Lett; 2018 Mar; 15(3):3746-3752. PubMed ID: 29467891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Zhou C; Wang Y; Ma L; Qian X; Yang C; Zeng M
    Eur Radiol; 2022 Jan; 32(1):78-88. PubMed ID: 34279688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography.
    Kim TM; Lee JM; Yoon JH; Joo I; Park SJ; Jeon SK; Schmidt B; Martin S
    Cancer Imaging; 2020 Aug; 20(1):60. PubMed ID: 32811570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
    Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
    Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma.
    Yang H; Han P; Huang M; Yue X; Wu L; Li X; Fan W; Li Q; Ma G; Lei P
    Abdom Radiol (NY); 2022 Mar; 47(3):948-956. PubMed ID: 34962593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.